For example, GH therapy should be performed carefully in patient 5 with IGF1R abnormality and patient 6 with SHORT syndrome, due to insulin resistance and a high risk of developing diabetes mellitus [24, 28]. This evidence concerns the gene GH1 and Insulin resistance.